Published in Genes Dev on April 17, 2006
The endocytic matrix. Nature (2010) 3.15
Endocytosis and signaling: cell logistics shape the eukaryotic cell plan. Physiol Rev (2012) 1.61
ChIPping away at gene regulation. EMBO Rep (2008) 1.54
Hbo1 Links p53-dependent stress signaling to DNA replication licensing. Mol Cell Biol (2007) 1.16
Mitotic moonlighting functions for membrane trafficking proteins. Traffic (2011) 1.06
A B-Myb complex containing clathrin and filamin is required for mitotic spindle function. EMBO J (2008) 1.05
Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis. Mol Oncol (2009) 1.01
NuMA is required for the selective induction of p53 target genes. Mol Cell Biol (2013) 0.88
Neonatal lethality in knockout mice expressing the kinase-dead form of the gefitinib target GAK is caused by pulmonary dysfunction. PLoS One (2011) 0.87
Unconventional functions for clathrin, ESCRTs, and other endocytic regulators in the cytoskeleton, cell cycle, nucleus, and beyond: links to human disease. Cold Spring Harb Perspect Biol (2014) 0.84
Heat shock factor-1 modulates p53 activity in the transcriptional response to DNA damage. Nucleic Acids Res (2009) 0.82
Protein adaptation: mitotic functions for membrane trafficking proteins. Nat Rev Mol Cell Biol (2013) 0.81
Increased gene copy number of VAMP7 disrupts human male urogenital development through altered estrogen action. Nat Med (2014) 0.81
Endocytosis-independent function of clathrin heavy chain in the control of basal NF-κB activation. PLoS One (2011) 0.79
The E3 ubiquitin protein ligase HERC2 modulates the activity of tumor protein p53 by regulating its oligomerization. J Biol Chem (2014) 0.79
Ndm, a coiled-coil domain protein that suppresses macropinocytosis and has effects on cell migration. Mol Biol Cell (2012) 0.78
Nuclear localization of clathrin involves a labile helix outside the trimerization domain. FEBS Lett (2012) 0.77
Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis. Sci Rep (2016) 0.76
EPSIN 3, A Novel p53 Target, Regulates the Apoptotic Pathway and Gastric Carcinogenesis. Neoplasia (2017) 0.75
NEURL4 regulates the transcriptional activity of tumor suppressor protein p53 by modulating its oligomerization. Oncotarget (2017) 0.75
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
Surfing the p53 network. Nature (2000) 35.36
A system for stable expression of short interfering RNAs in mammalian cells. Science (2002) 35.21
p53 mutations in human cancers. Science (1991) 31.96
p53, the cellular gatekeeper for growth and division. Cell (1997) 31.04
Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell (1997) 16.79
Functional interaction of beta-catenin with the transcription factor LEF-1. Nature (1996) 15.88
Regulated portals of entry into the cell. Nature (2003) 15.33
Live or let die: the cell's response to p53. Nat Rev Cancer (2002) 15.06
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett (1997) 11.19
A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature (1997) 11.15
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell (1997) 10.52
p53 has a direct apoptogenic role at the mitochondria. Mol Cell (2003) 8.98
Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science (2000) 8.74
The p53 pathway. J Pathol (1999) 6.79
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature (2000) 6.01
DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev (1997) 5.76
p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci (2001) 5.74
p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell (2000) 5.64
Decision making by p53: life, death and cancer. Cell Death Differ (2003) 5.52
Binding and modulation of p53 by p300/CBP coactivators. Nature (1997) 5.12
Recruitment of p300/CBP in p53-dependent signal pathways. Cell (1997) 5.10
ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell (2001) 4.38
Clathrin. Annu Rev Biochem (2000) 4.20
p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev (1996) 3.98
Nuclear actin and actin-related proteins in chromatin remodeling. Annu Rev Biochem (2001) 2.74
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet (2000) 2.69
DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J (1999) 2.50
Clathrin is required for the function of the mitotic spindle. Nature (2005) 2.45
Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J (1998) 2.09
Identification of a novel p53 functional domain that is necessary for mediating apoptosis. J Biol Chem (1998) 1.80
Regulation of clathrin assembly and trimerization defined using recombinant triskelion hubs. Cell (1995) 1.80
Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol (2001) 1.72
Searching for a function for nuclear actin. Trends Cell Biol (2000) 1.70
A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene (2003) 1.67
Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein. EMBO J (2001) 1.62
The LxxLL motif: a multifunctional binding sequence in transcriptional regulation. Trends Biochem Sci (2005) 1.41
Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress. Neoplasia (2000) 1.36
p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Res (2003) 1.32
Loss of p53 and centrosome hyperamplification. Oncogene (2002) 1.32
Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity. Oncogene (1999) 1.23
ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC). Mod Pathol (2003) 1.15
Implication of p53 in base excision DNA repair: in vivo evidence. Oncogene (2002) 1.14
The retinoblastoma protein binds the promoter of the survival gene bcl-2 and regulates its transcription in epithelial cells through transcription factor AP-2. Mol Cell Biol (2002) 1.10
Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1. J Biol Chem (2003) 1.09
Identification of human granzyme B promoter regulatory elements interacting with activated T-cell-specific proteins: implication of Ikaros and CBF binding sites in promoter activation. Proc Natl Acad Sci U S A (1995) 1.07
p53 mutations in bladder tumors from arylamine-exposed workers. Cancer Res (1996) 0.99
Clathrin light and heavy chain interface: alpha-helix binding superhelix loops via critical tryptophans. EMBO J (2002) 0.96
p53: 25 years of research and more questions to answer. Cell Death Differ (2003) 0.94
Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol (2004) 6.55
Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway. Nat Cell Biol (2006) 5.34
CIP2A inhibits PP2A in human malignancies. Cell (2007) 5.28
Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature (2007) 5.14
A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription. Cancer Cell (2010) 3.47
Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol (2002) 3.24
Epigenetic control of rDNA loci in response to intracellular energy status. Cell (2008) 3.22
p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron (2005) 3.13
Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3beta. Genes Dev (2004) 2.94
Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis. Oncogene (2002) 2.50
Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity (2009) 2.05
Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties. Blood (2002) 1.79
Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer. J Biol Chem (2012) 1.72
Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition. Cancer Res (2008) 1.68
Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria. J Biol Chem (2005) 1.67
PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt. Cell (2009) 1.65
Cyclin G recruits PP2A to dephosphorylate Mdm2. Mol Cell (2002) 1.57
MOZ is essential for maintenance of hematopoietic stem cells. Genes Dev (2006) 1.56
DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation. Mol Cell Biol (2005) 1.56
Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage. EMBO J (2007) 1.52
Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation. EMBO J (2002) 1.45
Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation. EMBO J (2006) 1.37
Mutations and deletions of the CBP gene in human lung cancer. Clin Cancer Res (2005) 1.34
Direct involvement of CREB-binding protein/p300 in sequence-specific DNA binding of virus-activated interferon regulatory factor-3 holocomplex. J Biol Chem (2002) 1.32
Excess HDM2 impacts cell cycle and apoptosis and has a selective effect on p53-dependent transcription. J Biol Chem (2006) 1.28
Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase. FEBS Lett (2009) 1.24
Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage. Mol Cell Biol (2006) 1.22
Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2. Proc Natl Acad Sci U S A (2008) 1.22
Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export. Oncogene (2003) 1.21
MOZ increases p53 acetylation and premature senescence through its complex formation with PML. Proc Natl Acad Sci U S A (2013) 1.19
PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation. Mol Cell Biol (2008) 1.17
p53AIP1 regulates the mitochondrial apoptotic pathway. Cancer Res (2002) 1.16
Sirt1 physically interacts with Tip60 and negatively regulates Tip60-mediated acetylation of H2AX. Biochem Biophys Res Commun (2009) 1.14
The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis. Blood (2011) 1.14
Nemo-like kinase suppresses a wide range of transcription factors, including nuclear factor-kappaB. Cancer Sci (2004) 1.14
PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2. Nat Med (2010) 1.12
Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro. J Biochem (2005) 1.11
KAP1 dictates p53 response induced by chemotherapeutic agents via Mdm2 interaction. Biochem Biophys Res Commun (2006) 1.10
Identification of novel human Cdt1-binding proteins by a proteomics approach: proteolytic regulation by APC/CCdh1. Mol Biol Cell (2007) 1.09
Retracted Regulation of p53: intricate loops and delicate balances. Biochem Pharmacol (2002) 1.05
Cyclin-dependent kinases phosphorylate p73 at threonine 86 in a cell cycle-dependent manner and negatively regulate p73. J Biol Chem (2003) 1.05
Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis. Cancer Sci (2008) 1.04
Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway. Mol Cell Biol (2004) 1.04
Cytoplasmic tethering is involved in synergistic inhibition of p53 by Mdmx and Mdm2. Cancer Sci (2009) 1.03
Dissecting functional roles of p53 N-terminal transactivation domains by microarray expression analysis. Cancer Sci (2007) 1.02
Regulation of p53: intricate loops and delicate balances. Ann N Y Acad Sci (2002) 1.01
PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiation. Mol Cell Biol (2007) 1.00
PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies. Proc Natl Acad Sci U S A (2013) 1.00
Monocytic leukemia zinc finger (MOZ) interacts with p53 to induce p21 expression and cell-cycle arrest. J Biol Chem (2008) 0.98
Protein kinase inhibitor 2-aminopurine overrides multiple genotoxic stress-induced cellular pathways to promote cell survival. Oncogene (2003) 0.95
Requirement of ATM for rapid p53 phosphorylation at Ser46 without Ser/Thr-Gln sequences. Mol Cell Biol (2010) 0.94
Physical and functional link of the leukemia-associated factors AML1 and PML. Blood (2004) 0.94
Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis. J Biol Chem (2008) 0.93
A role of p73 in mitotic exit. J Biol Chem (2005) 0.92
Proteolytically cleaved MLL subunits are susceptible to distinct degradation pathways. J Cell Sci (2011) 0.92
Cytoplasmic translocation of the retinoblastoma protein disrupts sarcomeric organization. Elife (2013) 0.90
Brpf1, a subunit of the MOZ histone acetyl transferase complex, maintains expression of anterior and posterior Hox genes for proper patterning of craniofacial and caudal skeletons. Dev Biol (2009) 0.90
NuMA is required for the selective induction of p53 target genes. Mol Cell Biol (2013) 0.88
Chromatin regulation by AML1 complex. Int J Hematol (2007) 0.87
MLL fusion proteins link transcriptional coactivators to previously active CpG-rich promoters. Nucleic Acids Res (2014) 0.86
Missense mutation and defective function of ATM in a childhood acute leukemia patient with MLL gene rearrangement. Blood (2003) 0.85
Cancer susceptibility polymorphism of p53 at codon 72 affects phosphorylation and degradation of p53 protein. J Biol Chem (2011) 0.85
Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo. Mol Cancer Ther (2004) 0.83
TEL/ETV6 binds to corepressor KAP1 via the HLH domain. Int J Hematol (2006) 0.83
Deregulated transcription factors in leukemia. Int J Hematol (2011) 0.82
β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells. Gastroenterology (2011) 0.81
Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion. Int J Hematol (2013) 0.81
Regulation of clathrin-mediated endocytosis by p53. Genes Cells (2008) 0.81
RUNX1 permits E4orf6-directed nuclear localization of the adenovirus E1B-55K protein and associates with centers of viral DNA and RNA synthesis. J Virol (2008) 0.80
Identification of a function-specific mutation of clathrin heavy chain (CHC) required for p53 transactivation. J Mol Biol (2009) 0.80
Augmentation of NK cell-mediated cytotoxicity to tumor cells by inhibitory NK cell receptor blockers. Int Immunol (2004) 0.79
Nuclear export signal within CALM is necessary for CALM-AF10-induced leukemia. Cancer Sci (2014) 0.79
Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons. J Biol Chem (2011) 0.79
MLL becomes functional through intra-molecular interaction not by proteolytic processing. PLoS One (2013) 0.79
Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated (ATM) gene in childhood Hodgkin disease. Blood (2003) 0.79
PML-RARα and its phosphorylation regulate pml oligomerization and HIPK2 stability. Cancer Res (2013) 0.78
Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells. Cancer Sci (2015) 0.78
Roles of AML1/RUNX1 in T-cell malignancy induced by loss of p53. Cancer Sci (2013) 0.78
Interactomic approach for evaluating nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma. Electrophoresis (2013) 0.77
PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1. Biochem Biophys Res Commun (2008) 0.77
Phosphorylation of Runx1 at Ser249, Ser266, and Ser276 is dispensable for bone marrow hematopoiesis and thymocyte differentiation. Biochem Biophys Res Commun (2008) 0.77
Interaction between RB protein and NuMA is required for proper alignment of spindle microtubules. Genes Cells (2013) 0.76
[Transcriptional regulation]. Nihon Rinsho (2012) 0.75
[I. Identification of a Possible Therapeutic Target for Chondrosarcoma with IDH Mutant Inhibitors]. Gan To Kagaku Ryoho (2017) 0.75
[IDH mutations activate Hoxa9/Meis1 and hypoxia pathways in acute myeloid leukemia model mice]. Rinsho Ketsueki (2015) 0.75